Webinar: Exploring Multicomponent COVID-19 Mutant Variant Analysis of Immunity Indicators in Human Serum
Learn about how Bio-Techne’s large panels of high-quality Spike Receptor Binding Domain (RBD) variants and ACE-2 protein were used to screen COVID-19 samples by HT-SPR using Carterra’s LSA.
Join Dr. Anthony Person from Bio-Techne and Noah Ditto from Carterra to discover how they are studying COVID-19 mutant variants in human serum samples to gain a more sophisticated understanding of patient immunity.
Learn about Bio-Techne’s large panels of high-quality Spike Receptor Binding Domain (RBD) variants and ACE-2 protein and how using Carterra’s LSA to perform HT-SPR screening of COVID-19 vaccinee serum samples can generate a wealth of information on immunity characterization using only a small amount of material.
- Hear about a diverse panel of high-quality RBD variants and ACE-2 protein available to support detailed analysis of COVID-19 and the evolving variants.
- Learn how serum samples from COVID-19 vaccinated patients are easily analyzed on the Carterra LSA using HT-SPR to identify markers of patient immunity using only microliter amounts of material.
- Listen to an experimental example of how scientists are gaining a more sophisticated understanding of immunity by leveraging the LSA's throughput, sample efficiency, and sensitivity.